Saturday, December 2, 2023
wellness India Expo
Home Tags Eli Lilly

Tag: Eli Lilly

Novo Nordisk, Eli Lilly record growth in Q2 driven by obesity,...

Both Lilly and Novo are projected to experience ongoing market capitalization growth, aligned with the expanding prospects of Lilly's Mounjaro and Novo's Wegovy and Ozempic

Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer’s...

The Elecsys Amyloid Plasma Panel has demonstrated clinical performance and is currently undergoing additional investigation to ensure clinical validation

Eli Lilly forays into dermatological space, launches psoriasis drug Copellor in...

Post approval from the Drugs Controller General of India, the drug will be available for treatment of adults with moderate-to-severe plaque psoriasis

Vineet Gupta appointed as the General Manager of Elli Lilly India

Vineet will take over from Luca Visini who served as Managing Director of the company in India from February 2018 to December 2021

Eli Lilly & Cipla enter into a strategic partnership in India...

Cipla will leverage its capabilities and robust distribution strengths to engage healthcare professionals and expand access to these treatments for patients who need them...................

“We will venture into newer therapy areas, expect to launch an...

Luca Visini, Managing Director, Eli Lilly & Company India shares his views on a variety of questions related to the company's operations in an exclusive interaction with BioVoice....................

“We aim to bring newer drug innovations to the Indian market”

Mentioned Luca Visini, Managing Director, Eli Lilly & Company India in an exclusive interaction with BioVoice where he outlined the goals of his company driven by innovation including pursual of new drug development and working towards medicines reaching people at large through different channels.....................

Healthcare firms finding obesity market a challenge to penetrate, says GlobalData

The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............

Eli Lilly India launches Humalog 200U/mL KwikPen

The product contains 200 U/mL rapid acting insulin, delivers the same benefits of Humalog 100U/mL in half the volume and operates with a much smoother glide force.....

“We plan to strengthen our diabetes product portfolio by 2018”

Mentioned Mr Edgard A. Olaizola who serves as the Managing Director of Eli Lilly and Company (India) since September 1, 2013. Mr Olaizola has with him over 13 years of diversified experience in Lilly.....